The following is a summary of “Substance Use and Use Disorders During Pregnancy and the Postpartum Period,” published in the ...

They provide current information on the diagnosis and treatment of postpartum mood and anxiety disorders; advocate research into etiology, diagnosis, and treatment of postpartum mood and anxiety ...

Jaundice is a common condition that affects more than half of full-term babies, but how much do you know about it? Here’s ...

While each death is a result of individual and often complex factors ranging from pre-existing health conditions to postpartum depression, the vast majority of Tennessee maternal deaths– 76%– were ...

Getting your Trinity Audio player ready... The Suda Institute has received a $100,000 grant from the Department of Health and Human Services’ Health Resources and Services Administration (HRSA) for ...

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

A new study showed that post-traumatic stress disorder and anxiety are associated with lower levels of anti-Müllerian hormone ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

Sage Therapeutics has a unique approach to targeting GABA, which allows it to target CNS disorders. Read why I think SAGE ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.